×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EPIX – essa pharma inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EPIX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
10/9
07:11 am
epix
ESSA Announces Completion of Arrangement with XenoTherapeutics [Yahoo! Finance]
Neutral
Report
ESSA Announces Completion of Arrangement with XenoTherapeutics [Yahoo! Finance]
10/9
07:00 am
epix
ESSA Announces Completion of Arrangement with XenoTherapeutics
Neutral
Report
ESSA Announces Completion of Arrangement with XenoTherapeutics
10/6
05:30 pm
epix
ESSA Securityholders Approve Acquisition by XenoTherapeutics [Yahoo! Finance]
Low
Report
ESSA Securityholders Approve Acquisition by XenoTherapeutics [Yahoo! Finance]
10/6
05:14 pm
epix
ESSA Securityholders Approve Acquisition by XenoTherapeutics
Low
Report
ESSA Securityholders Approve Acquisition by XenoTherapeutics
10/3
06:24 pm
epix
ESSA Pharma Inc. (EPIX) Shareholder/Analyst Call Prepared Remarks Transcript [Seeking Alpha]
Low
Report
ESSA Pharma Inc. (EPIX) Shareholder/Analyst Call Prepared Remarks Transcript [Seeking Alpha]
10/3
03:35 pm
epix
ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
9/30
04:30 pm
epix
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
Medium
Report
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
9/24
06:12 am
epix
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics [Yahoo! Finance]
High
Report
ESSA Pharma Inc. Amends Agreement with XenoTherapeutics [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
10/9
08:47 am
epix
Form 25-NSE ESSA Pharma Inc. Filed by: Nasdaq Stock Market LLC
Neutral
Report
Form 25-NSE ESSA Pharma Inc. Filed by: Nasdaq Stock Market LLC
10/9
07:01 am
epix
Form 8-K ESSA Pharma Inc. For: Oct 09
Neutral
Report
Form 8-K ESSA Pharma Inc. For: Oct 09
10/7
04:13 pm
epix
Form SCHEDULE 13G/A ESSA Pharma Inc. Filed by: MORGAN STANLEY
Low
Report
Form SCHEDULE 13G/A ESSA Pharma Inc. Filed by: MORGAN STANLEY
10/6
05:19 pm
epix
Form 8-K ESSA Pharma Inc. For: Oct 03
Low
Report
Form 8-K ESSA Pharma Inc. For: Oct 03
10/3
06:06 am
epix
Form 8-K ESSA Pharma Inc. For: Sep 30
Medium
Report
Form 8-K ESSA Pharma Inc. For: Sep 30
9/30
04:31 pm
epix
Form 8-K ESSA Pharma Inc. For: Sep 30
Medium
Report
Form 8-K ESSA Pharma Inc. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/23
ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement
27.9%
10/9 Form F-3 ESSA Pharma Inc. 9.4%
8/27 ESSA Pharma closes $36M capital raise [Seeking Alpha] 8.7%
9/19 ESSA to Present at Ladenburg Thalmann Healthcare Conference 7.0%
6/25 ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders 6.9%
10/10 ESSA Pharma: Promising Novel Therapy For Treatment Of Prostate Cancer [Seeking Alpha] 6.2%
10/28 ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 5.7%
7/30 ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics 5.6%
3/2 Realtor Credits New Immunotherapy for Destroying the Cancer That Threatened His Life 5.6%
8/28 Form 6-K ESSA Pharma Inc. For: Aug 27 5.1%
10/9 Form F-3 ESSA Pharma Inc. 9.4%
8/27 ESSA Pharma closes $36M capital raise [Seeking Alpha] 8.7%
9/19 ESSA to Present at Ladenburg Thalmann Healthcare Conference 7.0%
6/25 ESSA Pharma Inc. Reports Results of Annual General Meeting of Shareholders 6.9%
10/10 ESSA Pharma: Promising Novel Therapy For Treatment Of Prostate Cancer [Seeking Alpha] 6.2%
10/28 ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 5.7%
7/30 ESSA Announces Court Sanction of the Scheme of Arrangement with Realm Therapeutics 5.6%
3/2 Realtor Credits New Immunotherapy for Destroying the Cancer That Threatened His Life 5.6%
8/28 Form 6-K ESSA Pharma Inc. For: Aug 27 5.1%
TOP News Decliners
7/31
Form 6-K ESSA Pharma Inc. For: Jul 31
-15.9%
5/16 ESSA Pharma Inc (NASDAQ: EPIX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -11.9%
5/28 Form 6-K ESSA Pharma Inc. For: May 24 -7.3%
5/10 Q2/2019 3/31/2019 EPS -0.540 ZacksConsensus -0.440 ActVsEst (0.100) - Miss -7.2%
8/23 ATGE, FL, FSLY and TELL among midday movers [Seeking Alpha] -4.3%
8/30 Form SC 13G ESSA Pharma Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC -3.3%
5/23 Form SC 13D ESSA Pharma Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC -2.8%
2/28 Form 6-K ESSA Pharma Inc. For: Feb 27 -2.2%
6/28 Form SC 13G/A ESSA Pharma Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P -2.0%
7/8 Form 6-K ESSA Pharma Inc. For: Jul 08 -1.7%
5/16 ESSA Pharma Inc (NASDAQ: EPIX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -11.9%
5/28 Form 6-K ESSA Pharma Inc. For: May 24 -7.3%
5/10 Q2/2019 3/31/2019 EPS -0.540 ZacksConsensus -0.440 ActVsEst (0.100) - Miss -7.2%
8/23 ATGE, FL, FSLY and TELL among midday movers [Seeking Alpha] -4.3%
8/30 Form SC 13G ESSA Pharma Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC -3.3%
5/23 Form SC 13D ESSA Pharma Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC -2.8%
2/28 Form 6-K ESSA Pharma Inc. For: Feb 27 -2.2%
6/28 Form SC 13G/A ESSA Pharma Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P -2.0%
7/8 Form 6-K ESSA Pharma Inc. For: Jul 08 -1.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: